Adicet Bio shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Adicet Bio (ACET) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Adicet Bio
Tip: Access up to 7 years of quarterly data
All positions including Adicet Bio held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Adicet Bio by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $54k | 29k | 1.89 |
| 2023-09-30 | $82k | 60k | 1.37 |
| 2023-06-30 | $170k | 70k | 2.43 |
| 2023-03-31 | $572k | 99k | 5.76 |
| 2022-12-31 | $2.6M | 288k | 8.94 |
| 2022-06-30 | $5.0M | 346k | 14.60 |
| 2022-03-31 | $4.6M | 228k | 19.97 |
| 2021-12-31 | $2.9M | 164k | 17.49 |
| 2021-09-30 | $299k | 38k | 7.87 |
| 2021-03-31 | $598k | 46k | 13.07 |
| 2020-12-31 | $144k | 10k | 14.06 |